Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 P-glycoprotein and multidrug resistance in cancer chemotherapy.

× No keyword cloud information.

14 in total

Review 1. Active efflux mechanisms for antimicrobial resistance.

Authors: S B Levy
Journal: Antimicrob Agents Chemother Date: 1992-04 Impact factor: 5.191

2. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.

Authors: H Hächler; S P Cohen; S B Levy
Journal: J Bacteriol Date: 1991-09 Impact factor: 3.490

3. Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.

Authors: K Mross; U Mayer; K Hamm; K Burk; D K Hossfeld
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

4. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma.

Authors: C A Axiotis; C Monteagudo; M J Merino; N LaPorte; R D Neumann
Journal: Am J Pathol Date: 1991-04 Impact factor: 4.307

Review 5. Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors: H Bier
Journal: Eur Arch Otorhinolaryngol Date: 1993 Impact factor: 2.503

Review 6. Modulation of tumor cell response to chemotherapy by the organ environment.

Authors: I J Fidler; C Wilmanns; A Staroselsky; R Radinsky; Z Dong; D Fan
Journal: Cancer Metastasis Rev Date: 1994-06 Impact factor: 9.264

7. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta.

Authors: A MacFarland; D R Abramovich; S W Ewen; C K Pearson
Journal: Histochem J Date: 1994-05

8. PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia.

Authors: C F Rochlitz; E de Kant; A Neubauer; I Heide; R Böhmer; J Oertel; D Huhn; R Herrmann
Journal: Ann Hematol Date: 1992-12 Impact factor: 3.673

9. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.

Authors: M Dietel; I Herzig; A Reymann; I Brandt; B Schaefer; A Bunge; H J Heidebrecht; A Seidel
Journal: J Cancer Res Clin Oncol Date: 1994 Impact factor: 4.553

Review 10. Nucleoside salvage and resistance to antimetabolite anticancer agents.

Authors: M Fox; J M Boyle; A R Kinsella
Journal: Br J Cancer Date: 1991-09 Impact factor: 7.640